Notably, Il12rb2 knockout mice develop an autoimmune and lymphoproliferative disorder characterized by oligoclonal B cell proliferation and up-regulation of systemic IL-636, suggesting that increased IL12 signaling mediates anti-BCL immunity. Here, IL12RB2 is linked to lymphoproliferative syndrome.